57 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
of the statutory formula, also referred to as the Sustainable Growth Rate, for clinician payment and established a quality payment incentive program, also … Models, or APMs, and the Merit-based Incentive Payment System, or MIPS.The full impact to overall physician reimbursement under the Medicare program
F-3
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
value CHF 1/13 per share, in connection with our equity incentive plans.
Under our articles of association, as amended on December 8, 2022, our share … of its subsidiaries under the terms of one or more equity incentive plans or regulations adopted by the board of directors. Further, our shareholders
F-3
EX-4.1
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
or of one of its subsidiaries according to one or several equity incentive plans adopted by the board of directors; e) the acquisition of companies … or consultants of the company or of one of its subsidiaries under the terms of one or more equity incentive plans or regulations adopted by the board
6-K
OBSVF
ObsEva SA
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
payment incentive program, also referred to as the Quality Payment Program. This program provides clinicians with two ways to participate, including … through the Advanced Alternative Payment Models, or APMs, and the Merit-based Incentive Payment System, or MIPS. In November 2019, CMS issued a final
6-K
EX-99.1
OBSVF
ObsEva SA
19 May 22
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
7:05am
the proposed increase of ObsEva SA’s Conditional Share Capital for Equity Plans
Shareholders approved the proposed change to ObsEva SA’s Equity Incentive
6-K
5bl5x
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
6-K
EX-99.1
ujp drefs710mtm78
7 Apr 22
ObsEva Annual General Meeting 2022
7:01am
424B7
j83h4 qn550hn4
3 Mar 22
Prospectus with selling stockholder info
4:43pm
S-8
3z9avcj
2 Mar 22
Registration of securities for employees
4:48pm
S-8
036g5aputvr ljwq
2 Mar 22
Registration of securities for employees
4:48pm
S-8
EX-5.1
b9e1x0ae
2 Mar 22
Registration of securities for employees
4:48pm
F-3
EX-4.1
8ekmau38kwz rg3u33bl
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
inchnq4 j7
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
jdha7 ffc5
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
0d4h85b 5rw0ke2j11p
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
yo1db
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.2
ka73olyq2wx zu4ly7r0
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
8gg8x9 kq21urgp4es
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
6r7q sf4r
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am